Rosmantuzumab: A Deep Dive into OMP-131R10 Rosmantuzumab, previously known as OMP-131R10, represents a new monoclonal antibody developed to block granulocyte-macrophage colony-stimulating factor. Its mode of action https://www.targetmol.com/compound/rosmantuzumab